TradingView
swish30
Oct 1, 2017 3:58 PM

ATNM - Potential bottom reversal Long

Actinium Pharmaceuticals, Inc. (Delaware)Arca

Description

Insiders bought recently before the offering at $1.10 per share. Slightly risky when Actimab-A Phase 2 results could come out anytime.
More